# Rush Enterprises Inc \\TX\\: financial statements, quarterly

RUSHA · Nasdaq · CIK 1012019 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rusha.md) · [Financials](/companies/rusha/financials.md) · [Filings](/companies/rusha/filings.md) · [Insiders](/companies/rusha/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rusha/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,891](/filings/0001437749-24-033921.md) | [1,940 d](/filings/0001437749-26-005424.md) | [1,784](/filings/0001437749-25-015788.md) | [1,939](/filings/0001437749-25-025731.md) | [1,807](/filings/0001437749-25-033857.md) | [1,919 d](/filings/0001437749-26-005424.md) | [1,761](/filings/0001437749-26-015906.md) | [1,838](/filings/0001437749-26-026588.md) | [1,787](/filings/0001437749-25-033857.md) | [1,679 d](/filings/0001437749-26-005424.md) | [1,592](/filings/0001437749-26-015906.md) | [1,805](/filings/0001437749-26-026588.md) |
| Cost of revenue | $m | [1,586](/filings/0001437749-24-033921.md) | [1,643 d](/filings/0001437749-26-005424.md) | [1,482](/filings/0001437749-25-015788.md) | [1,635](/filings/0001437749-25-025731.md) | [1,517](/filings/0001437749-25-033857.md) | [1,639 d](/filings/0001437749-26-005424.md) | [1,493](/filings/0001437749-26-015906.md) | [1,551](/filings/0001437749-26-026588.md) | [1,506](/filings/0001437749-25-033857.md) | [1,423 d](/filings/0001437749-26-005424.md) | [1,340](/filings/0001437749-26-015906.md) | [1,538](/filings/0001437749-26-026588.md) |
| Gross profit | $m | [394](/filings/0001437749-24-033921.md) | [386 d](/filings/0001437749-26-005424.md) | [390](/filings/0001437749-25-015788.md) | [392](/filings/0001437749-25-025731.md) | [379](/filings/0001437749-25-033857.md) | [370 d](/filings/0001437749-26-005424.md) | [358](/filings/0001437749-26-015906.md) | [380](/filings/0001437749-26-026588.md) | [375](/filings/0001437749-25-033857.md) | [348 d](/filings/0001437749-26-005424.md) | [344](/filings/0001437749-26-015906.md) | [362](/filings/0001437749-26-026588.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [257](/filings/0001437749-24-033921.md) | [251 d](/filings/0001437749-26-005424.md) | [264](/filings/0001437749-25-015788.md) | [251](/filings/0001437749-25-025731.md) | [240](/filings/0001437749-25-033857.md) | [241 d](/filings/0001437749-26-005424.md) | [249](/filings/0001437749-26-015906.md) | [252](/filings/0001437749-26-026588.md) | [256](/filings/0001437749-25-033857.md) | [239 d](/filings/0001437749-26-005424.md) | [243](/filings/0001437749-26-015906.md) | [245](/filings/0001437749-26-026588.md) |
| Operating income | $m | [122](/filings/0001437749-24-033921.md) | [120 d](/filings/0001437749-26-005424.md) | [111](/filings/0001437749-25-015788.md) | [124](/filings/0001437749-25-025731.md) | [121](/filings/0001437749-25-033857.md) | [112 d](/filings/0001437749-26-005424.md) | [91.9](/filings/0001437749-26-015906.md) | [110](/filings/0001437749-26-026588.md) | [100](/filings/0001437749-25-033857.md) | [91.7 d](/filings/0001437749-26-005424.md) | [82.2](/filings/0001437749-26-015906.md) | [97.2](/filings/0001437749-26-026588.md) |
| Interest expense | $m | [14.2](/filings/0001437749-23-031173.md) | [16.3 d](/filings/0001437749-26-005424.md) | [18.0](/filings/0001437749-24-015965.md) | [19.8](/filings/0001437749-25-025731.md) | [18.1](/filings/0001437749-25-033857.md) | [16.1 d](/filings/0001437749-26-005424.md) | [13.5](/filings/0001437749-26-015906.md) | [13.1](/filings/0001437749-26-026588.md) | [12.3](/filings/0001437749-25-033857.md) | [9.4 d](/filings/0001437749-26-005424.md) | [7.4](/filings/0001437749-26-015906.md) | [7.2](/filings/0001437749-26-026588.md) |
| Income tax | $m | [26.9](/filings/0001437749-24-033921.md) | [26.7 d](/filings/0001437749-26-005424.md) | [21.3](/filings/0001437749-25-015788.md) | [26.3](/filings/0001437749-25-025731.md) | [23.8](/filings/0001437749-25-033857.md) | [21.4 d](/filings/0001437749-26-005424.md) | [17.9](/filings/0001437749-26-015906.md) | [24.1](/filings/0001437749-26-026588.md) | [20.1](/filings/0001437749-25-033857.md) | [17.6 d](/filings/0001437749-26-005424.md) | [13.7](/filings/0001437749-26-015906.md) | [19.3](/filings/0001437749-26-026588.md) |
| Net income | $m | [80.3](/filings/0001437749-24-033921.md) | [78.0 d](/filings/0001437749-26-005424.md) | [71.6](/filings/0001437749-25-015788.md) | [78.7](/filings/0001437749-25-025731.md) | [79.1](/filings/0001437749-25-033857.md) | [74.8 d](/filings/0001437749-26-005424.md) | [60.3](/filings/0001437749-26-015906.md) | [72.4](/filings/0001437749-26-026588.md) | [66.7](/filings/0001437749-25-033857.md) | [64.3 d](/filings/0001437749-26-005424.md) | [61.5](/filings/0001437749-26-015906.md) | [72.8](/filings/0001437749-26-026588.md) |
| Diluted EPS | $ per share | [0.96](/filings/0001437749-24-033921.md) | not reported | [0.88](/filings/0001437749-25-015788.md) | [97.00](/filings/0001437749-25-025731.md) | [0.97](/filings/0001437749-25-033857.md) | not reported | [0.73](/filings/0001437749-26-015906.md) | [0.90](/filings/0001437749-26-026588.md) | [0.83](/filings/0001437749-25-033857.md) | not reported | [0.77](/filings/0001437749-26-015906.md) | [0.91](/filings/0001437749-26-026588.md) |
| Basic EPS | $ per share | [0.99](/filings/0001437749-24-033921.md) | not reported | [0.91](/filings/0001437749-25-015788.md) | [1.01](/filings/0001437749-25-025731.md) | [1.00](/filings/0001437749-25-033857.md) | not reported | [0.76](/filings/0001437749-26-015906.md) | [0.93](/filings/0001437749-26-026588.md) | [0.85](/filings/0001437749-25-033857.md) | not reported | [0.79](/filings/0001437749-26-015906.md) | [0.93](/filings/0001437749-26-026588.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [192](/filings/0001437749-23-031173.md) | [184](/filings/0001437749-25-004794.md) | [156](/filings/0001437749-24-015965.md) | [167](/filings/0001437749-24-025891.md) | [185](/filings/0001437749-24-033921.md) | [228](/filings/0001437749-26-005424.md) | [229](/filings/0001437749-25-015788.md) | [211](/filings/0001437749-25-025731.md) | [242](/filings/0001437749-25-033857.md) | [213](/filings/0001437749-26-026588.md) | [240](/filings/0001437749-26-015906.md) | [265](/filings/0001437749-26-026588.md) |
| Current assets | $m | [2,146](/filings/0001437749-23-031173.md) | [2,260](/filings/0001437749-25-004794.md) | [2,517](/filings/0001437749-24-015965.md) | [2,378](/filings/0001437749-24-025891.md) | [2,460](/filings/0001437749-24-033921.md) | [2,390](/filings/0001437749-26-005424.md) | [2,434](/filings/0001437749-25-015788.md) | [2,396](/filings/0001437749-25-025731.md) | [2,217](/filings/0001437749-25-033857.md) | [2,091](/filings/0001437749-26-026588.md) | [2,205](/filings/0001437749-26-015906.md) | [2,293](/filings/0001437749-26-026588.md) |
| Total assets | $m | [4,218](/filings/0001437749-24-033921.md) | [4,364](/filings/0001437749-26-005424.md) | [4,629](/filings/0001437749-24-015965.md) | [4,507](/filings/0001437749-25-025731.md) | [4,553](/filings/0001437749-25-033857.md) | [4,618](/filings/0001437749-26-005424.md) | [4,688](/filings/0001437749-26-015906.md) | [4,716](/filings/0001437749-26-026588.md) | [4,553](/filings/0001437749-25-033857.md) | [4,431](/filings/0001437749-26-026588.md) | [4,516](/filings/0001437749-26-015906.md) | [4,660](/filings/0001437749-26-026588.md) |
| Current liabilities | $m | [1,720](/filings/0001437749-23-031173.md) | [1,673](/filings/0001437749-25-004794.md) | [1,757](/filings/0001437749-24-015965.md) | [1,698](/filings/0001437749-24-025891.md) | [1,752](/filings/0001437749-24-033921.md) | [1,650](/filings/0001437749-26-005424.md) | [1,695](/filings/0001437749-25-015788.md) | [1,718](/filings/0001437749-25-025731.md) | [1,623](/filings/0001437749-25-033857.md) | [1,492](/filings/0001437749-26-026588.md) | [1,513](/filings/0001437749-26-015906.md) | [1,580](/filings/0001437749-26-026588.md) |
| Long-term debt | $m | [203](/filings/0001437749-23-031173.md) | [414](/filings/0001437749-25-004794.md) | [524](/filings/0001437749-24-015965.md) | [397](/filings/0001437749-24-025891.md) | [400](/filings/0001437749-24-033921.md) | [408](/filings/0001437749-26-005424.md) | [404](/filings/0001437749-25-015788.md) | [413](/filings/0001437749-25-025731.md) | [263](/filings/0001437749-25-033857.md) | [275](/filings/0001437749-26-026588.md) | [278](/filings/0001437749-26-015906.md) | [281](/filings/0001437749-26-026588.md) |
| Current portion of debt | $m | [105](/filings/0001437749-23-031173.md) | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001437749-25-025731.md) | [0.1](/filings/0001437749-25-033857.md) | [0.1](/filings/0001437749-26-026588.md) | [0.1](/filings/0001437749-26-015906.md) | [1.7](/filings/0001437749-26-026588.md) |
| Shareholders' equity | $m | [1,900](/filings/0001437749-23-031173.md) | [1,871](/filings/0001437749-25-004794.md) | [1,936](/filings/0001437749-24-015965.md) | [2,003](/filings/0001437749-24-025891.md) | [2,083](/filings/0001437749-24-033921.md) | [2,142](/filings/0001437749-26-005424.md) | [2,167](/filings/0001437749-25-015788.md) | [2,154](/filings/0001437749-25-025731.md) | [2,214](/filings/0001437749-25-033857.md) | [2,203](/filings/0001437749-26-026588.md) | [2,269](/filings/0001437749-26-015906.md) | [2,331](/filings/0001437749-26-026588.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [97.0 d](/filings/0001437749-24-033921.md) | [84.7 d](/filings/0001437749-26-005424.md) | [(155)](/filings/0001437749-25-015788.md) | [271 d](/filings/0001437749-25-025731.md) | [112 d](/filings/0001437749-25-033857.md) | [392 d](/filings/0001437749-26-005424.md) | [154](/filings/0001437749-26-015906.md) | [228 d](/filings/0001437749-26-026588.md) | [368 d](/filings/0001437749-25-033857.md) | [113 d](/filings/0001437749-26-005424.md) | [60.4](/filings/0001437749-26-015906.md) | [133 d](/filings/0001437749-26-026588.md) |
| Capital expenditure | $m | [103 d](/filings/0001437749-24-033921.md) | [79.8 d](/filings/0001437749-26-005424.md) | [79.1](/filings/0001437749-25-015788.md) | [93.4 d](/filings/0001437749-25-025731.md) | [132 d](/filings/0001437749-25-033857.md) | [129 d](/filings/0001437749-26-005424.md) | [108](/filings/0001437749-26-015906.md) | [114 d](/filings/0001437749-26-026588.md) | [96.6 d](/filings/0001437749-25-033857.md) | [81.0 d](/filings/0001437749-26-005424.md) | [66.0](/filings/0001437749-26-015906.md) | [82.3 d](/filings/0001437749-26-026588.md) |
| Dividends paid | $m | [13.6 d](/filings/0001437749-24-033921.md) | [13.5 d](/filings/0001437749-26-005424.md) | [13.9](/filings/0001437749-25-015788.md) | [13.4 d](/filings/0001437749-25-025731.md) | [14.0 d](/filings/0001437749-25-033857.md) | [14.3 d](/filings/0001437749-26-005424.md) | [14.4](/filings/0001437749-26-015906.md) | [14.5 d](/filings/0001437749-26-026588.md) | [14.8 d](/filings/0001437749-25-033857.md) | [14.6 d](/filings/0001437749-26-005424.md) | [15.3](/filings/0001437749-26-015906.md) | [15.2 d](/filings/0001437749-26-026588.md) |
| Share repurchases | $m | [43.2 d](/filings/0001437749-24-033921.md) | [105 d](/filings/0001437749-26-005424.md) | [5.6](/filings/0001437749-25-015788.md) | [3.9 d](/filings/0001437749-25-025731.md) | [0.3 d](/filings/0001437749-25-033857.md) | [5.9 d](/filings/0001437749-26-005424.md) | [29.6](/filings/0001437749-26-015906.md) | [87.4 d](/filings/0001437749-26-026588.md) | [7.4 d](/filings/0001437749-25-033857.md) | [70.5 d](/filings/0001437749-26-005424.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [85.3](/filings/0001437749-23-031173.md) | [84.8](/filings/0001437749-24-015965.md) | [84.2](/filings/0001437749-24-025891.md) | [84.0](/filings/0001437749-24-033921.md) | [81.5](/filings/0001437749-25-015788.md) | [80.8](/filings/0001437749-25-025731.md) | [81.9](/filings/0001437749-25-033857.md) | [82.4](/filings/0001437749-26-015906.md) | [80.5](/filings/0001437749-26-026588.md) | [80.6](/filings/0001437749-25-033857.md) | [79.9](/filings/0001437749-26-015906.md) | [80.2](/filings/0001437749-26-026588.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.